Calithera Biosciences, Inc.
CALADelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001496671
Calithera Biosciences, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on May 26, 2023; 29 institutions reported holding it in 13F filings for Q2 2022, worth $4.44M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Calithera Biosciences, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 23 | 23 | 0 |
| Shares | 1.65M | 1.54M | −111.5K (−6.8%) |
| Value | $5.02M | $5.01M | −$18.2K (−0.4%) |
New holders (3)
Institutions that held Calithera Biosciences, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 675 | $2.20K | 0.00% |
| Coppell Advisory Solutions Corp. | 675 | $2.20K | 0.00% |
| Arcus Capital Partners, LLC | 250 | $815 | 0.00% |
Sold out (3)
Institutions that held Calithera Biosciences, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Tower Research Capital LLC (TRC) | 2,647 | $8.00K |
| BNP Paribas Arbitrage, SA | 1,206 | $3.55K |
| Axiom Investment Management LLC | 250 | $0 |